CODX vs PSX · rev $3.9M vs P/E 17, rev $143.15B
Co-Diagnostics, Inc. Common Stock (CODX) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
CODX currently screens at market cap $31.4M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the CODX and PSX stock pages for the full models.
Not investment advice.